NEWS 2007 PRESS RELEASES March 07, 2007 ZYOMYX AWARDED GRANT FROM THE CD4 INITIATIVE AT IMPERIAL COLLEGE LONDON Hayward, Calif. - Mar. 07, 2007 - Zyomyx, Inc., a leader in chip-based bioanalytical technologies, today announced it has been selected by Imperial College London’s CD4 Initiative to work on a new treatment management tool for HIV/AIDS patients in developing countries. The Company will co-develop a novel test for counting CD4+ T-lymphocytes in blood, a parameter that is a key input into the treatment algorithm for HIV/AIDS. The new test will be designed to be suitable for widespread use in resource-poor countries. Zyomyx will receive milestone-dependent payments from Imperial College over the next four years for the development of this technology. Upon successful completion of the development program, the Company intends to manufacture the resulting product for global release. Imperial College’s CD4 Initiative is funded by the Bill & Melinda Gates Foundation. Media Contact   (510) 265-8000   info@zyomyx.com
		Home | News | Services | Employment | Contact Us Copyright © 2002 Zyomyx, Inc. All rights reserved Any reproduction wholly, or in-part of this website is prohibited without the express written authority of Zyomyx, Inc.